Log In
Print
BCIQ
Print
Print this Print this
 

NGAL Test

  Manage Alerts
Collapse Summary General Information
Company BioPorto Diagnostics A/S
DescriptionAn in vitro test that detects the lipocalin (LCN2; NGAL) biomarker produced in the kidneys
Molecular Target Lipocalin (LCN2) (NGAL)
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentMarketed
IndicationRenal, Diagnostic
Partner

Siemens AG
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today